Mark Lomax

519 total citations
21 papers, 305 citations indexed

About

Mark Lomax is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Animal Science and Zoology. According to data from OpenAlex, Mark Lomax has authored 21 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 16 papers in Pulmonary and Respiratory Medicine and 5 papers in Animal Science and Zoology. Recurrent topics in Mark Lomax's work include Inhalation and Respiratory Drug Delivery (16 papers), Asthma and respiratory diseases (14 papers) and Respiratory and Cough-Related Research (7 papers). Mark Lomax is often cited by papers focused on Inhalation and Respiratory Drug Delivery (16 papers), Asthma and respiratory diseases (14 papers) and Respiratory and Cough-Related Research (7 papers). Mark Lomax collaborates with scholars based in United Kingdom, Germany and Poland. Mark Lomax's co-authors include Michael Hopp, Frank Coffey, Patrick Dissmann, Sanjeeva Dissanayake, Anna Bodzenta­‐Łukaszyk, Beatrix Bálint, Sam H. Ahmedzai, Wojciech Leppert, Roland Buhl and A. Oksche and has published in prestigious journals such as The Lancet Neurology, European Respiratory Journal and Thorax.

In The Last Decade

Mark Lomax

20 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Lomax United Kingdom 8 115 108 84 61 56 21 305
J. Gallagher United Kingdom 3 45 0.4× 160 1.5× 17 0.2× 19 0.3× 24 0.4× 8 288
Emily Sussman United States 10 26 0.2× 77 0.7× 27 0.3× 120 2.0× 18 0.3× 10 282
Amit Verma United States 7 45 0.4× 22 0.2× 51 0.6× 28 0.5× 31 0.6× 17 232
Mario Patiño United States 9 94 0.8× 80 0.7× 5 0.1× 65 1.1× 20 0.4× 17 261
M. Cumming Canada 10 49 0.4× 31 0.3× 55 0.7× 136 2.2× 28 0.5× 18 383
Rack Kyung Chung South Korea 9 27 0.2× 31 0.3× 23 0.3× 77 1.3× 15 0.3× 45 290
Mark D. Willingham United States 8 63 0.5× 38 0.4× 9 0.1× 115 1.9× 11 0.2× 13 272
Christoph Hünseler Germany 11 14 0.1× 271 2.5× 13 0.2× 44 0.7× 133 2.4× 24 404
Nesrin Bozdoğan Türkiye 11 27 0.2× 40 0.4× 12 0.1× 147 2.4× 54 1.0× 23 326
Lauren Hill South Africa 8 103 0.9× 21 0.2× 12 0.1× 132 2.2× 33 0.6× 16 302

Countries citing papers authored by Mark Lomax

Since Specialization
Citations

This map shows the geographic impact of Mark Lomax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lomax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lomax more than expected).

Fields of papers citing papers by Mark Lomax

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lomax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lomax. The network helps show where Mark Lomax may publish in the future.

Co-authorship network of co-authors of Mark Lomax

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lomax. A scholar is included among the top collaborators of Mark Lomax based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lomax. Mark Lomax is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hartshorn, Stuart, Patrick Dissmann, Frank Coffey, & Mark Lomax. (2019). <p>Low-dose methoxyflurane analgesia in adolescent patients with moderate-to-severe trauma pain: a subgroup analysis of the STOP! study</p>. Journal of Pain Research. Volume 12. 689–700. 9 indexed citations
3.
4.
Bell, David, Lucielle Mansfield, & Mark Lomax. (2017). A Randomized, Crossover Trial Evaluating Patient Handling, Preference, and Ease of Use of the Fluticasone Propionate/Formoterol Breath-Triggered Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 30(6). 425–434. 10 indexed citations
5.
6.
7.
Kappeler, Dominik, et al.. (2017). Lung deposition of fluticasone propionate/formoterol administered via a breath-triggered inhaler. PA522–PA522. 2 indexed citations
8.
9.
10.
Bell, David, Lucielle Mansfield, & Mark Lomax. (2016). Fluticasone propionate/formoterol breath-triggered inhaler: Ease-of-use and patient preference. PA4109–PA4109. 1 indexed citations
11.
Trenkwalder, Claudia, К. Ray Chaudhuri, Pablo Martínez‐Martín, et al.. (2015). Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial. The Lancet Neurology. 14(12). 1161–1170. 90 indexed citations
12.
Papi, Alberto, David Price, J. Sastre, et al.. (2014). Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis. Respiratory Medicine. 109(2). 208–217. 7 indexed citations
13.
Ahmedzai, Sam H., et al.. (2014). Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain. Supportive Care in Cancer. 23(3). 823–830. 51 indexed citations
14.
Papi, Alberto, David Price, J. Sastre, et al.. (2013). Fluticasone propionate/formoterol fumarate improves asthma control and reduces exacerbations compared with fluticasone. European Respiratory Journal. 42(Suppl 57). P704–P704. 2 indexed citations
15.
Kanniess, Frank, Zuzana Diamant, Mark Lomax, & Meena Jain. (2013). Effects of low- vs high-dose fluticasone/formoterol combination therapy on AMP challenge in asthmatic patients. European Respiratory Journal. 42(Suppl 57). P3645–P3645. 2 indexed citations
16.
Kanniess, Frank, Zuzana Diamant, Mark Lomax, & Meena Jain. (2013). P166 Effects of low-vs high-dose fluticasone/formoterol combination therapy on AMP challenge in asthmatic patients. Thorax. 68(Suppl 3). A150.3–A151. 1 indexed citations
17.
18.
Tamm, Michael, et al.. (2011). Effects on adrenal function of a new combination of fluticasone propionate/formoterol fumarate administered to asthmatic patients and healthy subjects. 38. 4010. 2 indexed citations
19.
Price, David, et al.. (2011). Fluticasone propionate/formoterol fumarate combination therapy is equally effective and well-tolerated when administered with or without a spacer device to patients with asthma. 38. 3986. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Gallagher Breakdown of academic impact, for papers by Emily Sussman Breakdown of academic impact, for papers by Amit Verma Breakdown of academic impact, for papers by Mario Patiño Breakdown of academic impact, for papers by M. Cumming Breakdown of academic impact, for papers by Rack Kyung Chung Breakdown of academic impact, for papers by Mark D. Willingham Breakdown of academic impact, for papers by Christoph Hünseler Breakdown of academic impact, for papers by Nesrin Bozdoğan Breakdown of academic impact, for papers by Lauren Hill
Rankless by CCL
2026